NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

I agree pgsd. I believe the discussion about the high cost of new novel treatments, during the Q&A session after Dr. Ashkan's talk, was more about Optune and less about DCVax-L. In my opinion, DCVax-L is already fairly and competitively priced compared to other immunotherapy treatments, like CAR-T.

Especially, if in addition to the “Quality of Life” and efficacy (overall survival benefits) advantages of DCVax-L, you also factor in the comparative cost difference of each treatment over a 5-Year period (assuming an Optune patient can live for 5 years, and we certainly can not prove they can):

Optune treatment over a 5-Year period would cost:

$21,000 per month x 12 months x 5 years = $1,260,000

DCVax-L treatment over a 5-Year period would cost:

The cost of DCVax-L will get even better with commercial volume scale, and with incorporating Flaskworks into the production process.

About $200,000 per patient, for all of the DCVax-L vaccine doses needed for 5+ years survival